Lemborexant May Slow Alzheimer’s Progress by Targeting Sleep
A common sleep medication has shown promise in preventing the devastating damage seen in Alzheimer’s disease and related disorders. Lemborexant, an FDA-approved sleep aid, has been found to prevent harmful protein buildup and brain tissue loss in mice genetically engineered to develop Alzheimer’s-like symptoms. Research published in Nature Neuroscience suggests that targeting sleep problems early … Read more